Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 2, Randomized, Double-blind, Placebo-controlled Trial of Fosamprenavir-Sodium Alginate Administered Orally for 8 Weeks to Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease

The goal of this clinical trial is to learn if study drug Fosamprenavir-Sodium Alginate (FOS-SA) administered orally improves symptoms for Proton Pump Inhibito…

Refractory Gastroesophageal Reflux DiseaseGastroesophageal Reflux Disease

Medical College of WisconsinNCT06704100